Patient and provider attitudes regarding sudden unexpected death in epilepsy disclosure at a low-resource, minority community health center

• Published in: Epilepsy & behavior 2024-10, Vol.159, p.109969, Article 109969
• Main Authors: Schwartz, Kendall, Moussavi, Alireza, Bujan Figueredo, Reynaldo, Ghering, Julia, Redford, Wendy, Saririan, Shahrzad, Irwin, Chase, Buchhalter, Jeffrey
• Format: Article
• Language: English
• Subjects: Epilepsy; Health Disparities; Patient Attitudes; Provider Disclosure; SUDEP
• ISSN: 1525-5050; 1525-5069; 1525-5069
• DOI: 10.1016/j.yebeh.2024.109969

•Community health center patients with epilepsy knew little about SUDEP.•Patients with epilepsy who identify as Hispanic desire to know their risk of SUDEP.•These patients desire to know from their provider, and soon after diagnosis.•Primary care providers often do not disclose risk of SUDEP. Sudden Unexpected Death in Epilepsy (SUDEP) is a complication of epilepsy responsible for approximately 1 death per 1000 patients. The literature has demonstrated minimal SUDEP disclosure between providers and patients, although patients have consistently reported desire to know about their risk. However, the majority of these studies has been conducted in Caucasian populations which did not seek to include lower socio-economic class individuals. Thus, the purpose of this study is to determine patient and provider attitudes regarding SUDEP disclosure at a community health center serving minority, predominantly Hispanic, patients. This cross-sectional study utilized surveys distributed to patients with epilepsy (n = 20), patients with diabetes (n = 20), those with no chronic disease (n = 20) and providers (n = 13). Online surveys were distributed to 13 providers whereas phone surveys were conducted for patients with epilepsy. In-person surveys were distributed to patients with diabetes and no chronic disease to serve as comparison groups. Surveys were available in both Spanish and English. Patient surveys consisted of demographic information and questions evaluating their current knowledge and preferences regarding disclosure of a potentially fatal disorder. Twenty patients with epilepsy, 20 patients with diabetes, 20 patients without chronic diseases, and 9 providers responded to the online or in-person surveys. Of the patients with epilepsy, 90 % (n = 18/20) were Hispanic which was not significantly different from the comparison groups. 45 % (n = 9/20) believed they had a higher rate of death due to epilepsy with only 3 patients having heard of SUDEP prior to the survey, and only 1 learning this from a physician. All patients wanted to know everything there was to know regarding their condition, including a higher risk of unexpected death. Most patients (85%, n = 17/20) believe everyone with epilepsy should be informed of SUDEP and this information should come from their provider (90 %, n = 18/20). Results were similar for both comparison groups, except patients with diabetes unanimously desired to know about a theoretical risk of death at the time of diagnosis. Of t